Neochem Bio Solutions Ltd.
•₹ 96-3.57%
2026-08-21
PROS
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.7%
CONS
- Company has a high debt-to-equity of 1.80x
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.36x)
- Though reporting repeated profits, the company pays out little dividend (0.0%)
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SOLARINDS | 19800.00 | 89.97 | 179170.31 | 0.06 | 666.37 | 88.98 | 3668.20 | 70.26 | 38.16 | 27.91 |
| 2. | PIDILITIND | 1650.00 | 63.40 | 167935.41 | 1.30 | 8835.10 | 1202.86 | 45515.50 | 1112.74 | 32.38 | 26.28 |
| 3. | SRF | 2575.00 | 35.31 | 76329.39 | 0.35 | 758.87 | 75.53 | 5033.26 | 34.63 | 14.21 | 24.57 |
| 4. | FLUOROCHEM | 4679.55 | 83.59 | 51404.86 | 0.06 | 219.00 | 19.02 | 1588.00 | 23.97 | 10.02 | 26.83 |
| 5. | NAVINFLUOR | 8281.50 | 53.80 | 42484.11 | 0.18 | 243.31 | 107.67 | 1045.08 | 44.07 | 21.39 | 34.17 |
| 6. | GODREJIND | 1217.10 | 34.87 | 40998.14 | 0.00 | 523.36 | -27.85 | 5448.09 | 22.16 | 10.64 | 12.82 |
| 7. | DEEPAKNTR | 1767.85 | 30.78 | 24112.24 | 0.42 | 345.01 | 207.36 | 2577.60 | 36.39 | 11.58 | 20.96 |
| 8. | AETHER | 1639.40 | 92.52 | 21759.40 | 0.00 | 62.75 | 33.45 | 326.56 | 27.49 | 11.65 | 31.47 |
| 9. | ATUL | 6581.75 | 24.36 | 19377.83 | 0.46 | 253.93 | 91.85 | 1847.95 | 25.03 | 15.05 | 21.41 |
| 10. | AARTIIND | 526.90 | 35.99 | 19112.07 | 0.19 | 155.00 | 260.47 | 2387.00 | 42.42 | 6.39 | 16.00 |
| 11. | DEEPAKFERT | 1474.65 | 18.98 | 18678.34 | 0.68 | 490.04 | 100.95 | 3256.26 | 22.47 | 12.12 | 25.96 |
| 12. | NEOCHEM | 97.65 | 21.57 | 167.18 | 0.00 | — | — | — | — | 27.34 | — |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
No quarterly results found
We don't have this information yet. Please check back later.
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 48 | 61 | 84 | |
| 44 | 55 | 71 | |
| Operating Profit | 5 | 7 | 15 |
| OPM % | 10 | 11 | 18 |
| Other Income | 1 | 1 | 2 |
| Interest | 2 | 3 | 4 |
| Depreciation | 1 | 1 | 1 |
| 2 | 3 | 10 | |
| Tax % | 29 | 33 | 24 |
| Net Profit | 1 | 2 | 8 |
| EPS | 2 | 3 | 12 |
| Dividend Payout % | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 1 | 2 | 7 |
| Minority Interest | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 |
| Adjusted EPS | 1 | 2 | 7 |
Mar 2023
- 48
- 44
- Operating Profit
- 5
- OPM %
- 10
- Other Income
- 1
- Interest
- 2
- Depreciation
- 1
- 2
- Tax %
- 29
- Net Profit
- 1
- EPS
- 2
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2024
- 61
- 55
- Operating Profit
- 7
- OPM %
- 11
- Other Income
- 1
- Interest
- 3
- Depreciation
- 1
- 3
- Tax %
- 33
- Net Profit
- 2
- EPS
- 3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2025
- 84
- 71
- Operating Profit
- 15
- OPM %
- 18
- Other Income
- 2
- Interest
- 4
- Depreciation
- 1
- 10
- Tax %
- 24
- Net Profit
- 8
- EPS
- 12
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 27%
- Last Year:
- 49%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| LIABILITIES | - | - | - |
| Equity Capital | 5 | 7 | 7 |
| 3 | 5 | 13 | |
| 14 | 14 | 20 | |
| Trade Payables | 13 | 14 | 16 |
| 15 | 24 | 23 | |
| Total Liabilities | 51 | 64 | 79 |
| ASSETS | - | - | - |
| 15 | 19 | 19 | |
| 15 | 18 | 24 | |
| 0 | 17 | 25 | |
| 21 | 9 | 11 | |
| Total Assets | 51 | 64 | 79 |
| Total Debt | 26 | 33 | 36 |
| Net Working Capital | 3 | 6 | 9 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | 14.84 | 17.98 | 29.59 |
| Face Value | 10.00 | 10.00 | 10.00 |
| Total Debt | 26 | 33 | 36 |
| Net Working Capital | 3 | 6 | 9 |
| Contingent Liabilities | 0 | 0 | 0 |
| Book Value per Share | 14.84 | 17.98 | 29.59 |
| Face Value | 10.00 | 10.00 | 10.00 |
Mar 2023
- Equity Capital
- 5
- 3
- 14
- Trade Payables
- 13
- 15
- Total Liabilities
- 51
- 15
- 15
- 0
- 21
- Total Assets
- 51
- Total Debt
- 26
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 14.84
- Face Value
- 10.00
- Total Debt
- 26
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 14.84
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 7
- 5
- 14
- Trade Payables
- 14
- 24
- Total Liabilities
- 64
- 19
- 18
- 17
- 9
- Total Assets
- 64
- Total Debt
- 33
- Net Working Capital
- 6
- Contingent Liabilities
- 0
- Book Value per Share
- 17.98
- Face Value
- 10.00
- Total Debt
- 33
- Net Working Capital
- 6
- Contingent Liabilities
- 0
- Book Value per Share
- 17.98
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 7
- 13
- 20
- Trade Payables
- 16
- 23
- Total Liabilities
- 79
- 19
- 24
- 25
- 11
- Total Assets
- 79
- Total Debt
- 36
- Net Working Capital
- 9
- Contingent Liabilities
- 0
- Book Value per Share
- 29.59
- Face Value
- 10.00
- Total Debt
- 36
- Net Working Capital
- 9
- Contingent Liabilities
- 0
- Book Value per Share
- 29.59
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -1 | 2 | 3 | |
| Cash from Investing | -3 | -8 | -2 |
| Cash from Financing | 4 | 6 | -1 |
| -0 | 0 | -0 | |
| Free Cash Flow | -1 | -3 | 2 |
| OCF / Net Profit | -0.69 | 1.09 | 0.33 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
| OCF / Net Profit | -0.69 | 1.09 | 0.33 |
| Cumulative 5-Year FCF | 0 | 0 | 0 |
Mar 2023
- -1
- Cash from Investing
- -3
- Cash from Financing
- 4
- -0
- Free Cash Flow
- -1
- OCF / Net Profit
- -0.69
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.69
- Cumulative 5-Year FCF
- 0
Mar 2024
- 2
- Cash from Investing
- -8
- Cash from Financing
- 6
- 0
- Free Cash Flow
- -3
- OCF / Net Profit
- 1.09
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.09
- Cumulative 5-Year FCF
- 0
Mar 2025
- 3
- Cash from Investing
- -2
- Cash from Financing
- -1
- -0
- Free Cash Flow
- 2
- OCF / Net Profit
- 0.33
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.33
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| PER SHARE | - | - | - |
| EPS (₹) | 1.98 | 2.70 | 11.61 |
| Book Value (₹) | 14.84 | 17.98 | 29.59 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 2.41 | 2.59 | 7.77 |
| PROFITABILITY | - | - | - |
| Operating Margin % | 10.02% | 9.80% | 15.58% |
| Net Margin % | 2.23% | 2.95% | 9.21% |
| ROE % | 13.33% | 17.96% | 48.82% |
| ROCE % | 10.54% | 14.15% | 27.34% |
| 2.12% | 3.14% | 10.84% | |
| EFFICIENCY | - | - | - |
| Debtor Days | 109 | 94 | 92 |
| Inventory Days | 113 | 99 | 91 |
| Payable Days | 157 | 130 | 100 |
| 65 | 63 | 83 | |
| FINANCIAL HEALTH | - | - | - |
| Debt to Equity (x) | 3.26x | 2.78x | 1.80x |
| Interest Coverage (x) | 1.72x | 1.90x | 3.93x |
| 1.09x | 1.17x | 1.21x | |
| GROWTH | - | - | - |
| Revenue Growth % | 0.00% | 26.89% | 37.66% |
| Operating Profit Growth % | 0.00% | 41.84% | 120.31% |
| Net Profit Growth % | 0.00% | 67.89% | 330.28% |
| 0.00% | 36.48% | 330.28% | |
| VALUATION | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% |
| 0.00x | 5.79x | 2.80x |
Mar 2023
- EPS (₹)
- 1.98
- Book Value (₹)
- 14.84
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.41
- Operating Margin %
- 10.02%
- Net Margin %
- 2.23%
- ROE %
- 13.33%
- ROCE %
- 10.54%
- 2.12%
- Debtor Days
- 109
- Inventory Days
- 113
- Payable Days
- 157
- 65
- Debt to Equity (x)
- 3.26x
- Interest Coverage (x)
- 1.72x
- 1.09x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 2.70
- Book Value (₹)
- 17.98
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.59
- Operating Margin %
- 9.80%
- Net Margin %
- 2.95%
- ROE %
- 17.96%
- ROCE %
- 14.15%
- 3.14%
- Debtor Days
- 94
- Inventory Days
- 99
- Payable Days
- 130
- 63
- Debt to Equity (x)
- 2.78x
- Interest Coverage (x)
- 1.90x
- 1.17x
- Revenue Growth %
- 26.89%
- Operating Profit Growth %
- 41.84%
- Net Profit Growth %
- 67.89%
- 36.48%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 5.79x
Mar 2025
- EPS (₹)
- 11.61
- Book Value (₹)
- 29.59
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.77
- Operating Margin %
- 15.58%
- Net Margin %
- 9.21%
- ROE %
- 48.82%
- ROCE %
- 27.34%
- 10.84%
- Debtor Days
- 92
- Inventory Days
- 91
- Payable Days
- 100
- 83
- Debt to Equity (x)
- 1.80x
- Interest Coverage (x)
- 3.93x
- 1.21x
- Revenue Growth %
- 37.66%
- Operating Profit Growth %
- 120.31%
- Net Profit Growth %
- 330.28%
- 330.28%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 2.80x
Documents
Announcements
Nothing filed yet.
Annual Reports
Nothing filed yet.
Credit Ratings
Nothing filed yet.
Concalls
May 2026
Mar 2026